National Vision (NASDAQ:EYE) Shares Down 4.3% - Here's What Happened

Key Points

• Shares fell 4.3% intraday to $24.56 (low $24.50) with only 202,332 shares traded—an 84% drop versus the average session volume of 1,291,281.
• Analysts hold a consensus rating of "Moderate Buy" with a $31.21 target; eight analysts rate the stock Buy and six rate it Hold, with several firms raising targets (Citigroup to $40, UBS to $42).
• National Vision beat quarterly EPS ( $0.15 vs. $0.06) and saw revenue rise 15.1% to $503.41M, while issuing FY2026 guidance of $0.85–$1.09 EPS.

National Vision Holdings, Inc. (NASDAQ:EYE - Get Free Report)'s share price traded down 4.3% during mid-day trading on Monday . The stock traded as low as $24.50 and last traded at $24.56. 202,332 shares were traded during mid-day trading, a decline of 84% from the average session volume of 1,291,281 shares. The stock had previously closed at $25.67.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Wolfe Research set a $35.00 target price on shares of National Vision in a report on Wednesday, March 4th. Wells Fargo & Company increased their target price on shares of National Vision from $27.00 to $30.00 and gave the stock an "equal weight" rating in a report on Thursday, March 5th. Citigroup increased their target price on shares of National Vision from $35.00 to $40.00 and gave the stock a "buy" rating in a report on Thursday, March 5th. Wall Street Zen lowered shares of National Vision from a "buy" rating to a "hold" rating in a report on Saturday, March 28th. Finally, UBS Group increased their target price on shares of National Vision from $39.00 to $42.00 and gave the stock a "buy" rating in a report on Thursday, March 5th. Eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $31.21.

National Vision Stock Down 3.4%

The company has a current ratio of 0.55, a quick ratio of 0.33 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $1.97 billion, a P/E ratio of 67.04, a P/E/G ratio of 1.98 and a beta of 1.40. The company has a 50 day simple moving average of $26.88 and a two-hundred day simple moving average of $26.97.

National Vision (NASDAQ:EYE - Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.09. National Vision had a return on equity of 5.15% and a net margin of 1.49%.The business had revenue of $503.41 million during the quarter, compared to the consensus estimate of $495.26 million. During the same period in the prior year, the company posted ($0.04) EPS. The firm's revenue for the quarter was up 15.1% compared to the same quarter last year. National Vision has set its FY 2026 guidance at 0.850-1.090 EPS. On average, equities analysts predict that National Vision Holdings, Inc. will post 0.31 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Chairman L Reade Fahs sold 7,601 shares of the stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $29.58, for a total transaction of $224,837.58. Following the completion of the transaction, the chairman directly owned 694,880 shares in the company, valued at approximately $20,554,550.40. This represents a 1.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of EYE. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of National Vision by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,257 shares of the company's stock valued at $591,000 after acquiring an additional 1,948 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of National Vision by 6.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 235,125 shares of the company's stock valued at $3,005,000 after acquiring an additional 13,384 shares during the last quarter. Creative Planning bought a new position in shares of National Vision during the 2nd quarter valued at approximately $395,000. Walleye Capital LLC boosted its position in shares of National Vision by 29.4% during the 2nd quarter. Walleye Capital LLC now owns 27,127 shares of the company's stock valued at $624,000 after acquiring an additional 6,170 shares during the last quarter. Finally, Cerity Partners LLC boosted its position in shares of National Vision by 13.8% during the 2nd quarter. Cerity Partners LLC now owns 16,887 shares of the company's stock valued at $389,000 after acquiring an additional 2,049 shares during the last quarter.

National Vision Company Profile

National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.

Through its primary retail brands—including America's Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.